STACY SUMPTER: Open Payments
NPI 1518922913 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 20 payments from 11 companies in 2025. Trend: 2023 $299 · 2024 $434 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $91 |
| Organon LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Amgen Inc. | 2 | $38 |
| PFIZER INC. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
Products named: NEXPLANON, QULIPTA, INSPIRE, FARXIGA, VRAYLAR, PREVNAR 20, Tirosint, Prolastin-C Liquid.
Industry payments across UT — which companies pay providers there.
